We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.88%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.5B
AUM Growth
-$92.3M
(-5.8%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-13.12%
Top 10 Holdings %
Top 10 Hldgs %
47.1%
Holding
47
New
6
Increased
18
Reduced
8
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$54.9M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$52.1M |
| 3 |
Zoetis
ZTS
|
+$26.3M |
| 4 |
Eli Lilly
LLY
|
+$26.1M |
| 5 |
Humana
HUM
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$62.7M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$60.6M |
| 3 |
PNK
Pinnacle Entertainment Inc.
PNK
|
+$50.6M |
| 4 |
General Motors
GM
|
+$48.9M |
| 5 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.13% |
| 2 | Financials | 11.72% |
| 3 | Consumer Discretionary | 8.01% |
| 4 | Communication Services | 5.8% |
| 5 | Energy | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYTH
26
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $22.3M | 1.49% |
+444,999
| New | +$18.7M |
|
27
VeriSign
VRSN
$26.2B
| $21.5M | 1.44% |
321,709
-283,198
| -47% | -$17.2M |
|
28
Arrowhead Research
ARWR
$12B
| $20.1M | 1.35% |
2,976,183
+621,305
| +26% | +$4.41M |
|
29
Atara Biotherapeutics
ATRA
$74.4M
| $19.7M | 1.32% |
18,993
+9,255
| +95% | +$6.12M |
|
30
Cardiff Oncology
CRDF
$65.9M
| $19.4M | 1.3% |
39,591
+9,829
| +33% | +$4.19M |
|
|
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
| $17.8M | 1.19% |
473,256
+77,544
| +20% | +$3.08M |
|
32
CALL
Alerian MLP ETF
AMLP
$13B
| $16.6M | 1.11% |
200,000
| – | – |
|
|
WMGI
33
DELISTED
Wright Medical Group Inc
WMGI
| $13.8M | 0.92% |
533,638
-210,634
| -28% | -$5.42M |
|
34
Ironwood Pharmaceuticals
IRWD
$688M
| $13.4M | 0.9% |
+1,003,532
| New | +$13.2M |
|
35
Cameco
CCJ
$37.8B
| $11.3M | 0.76% |
813,586
+574,280
| +240% | +$8.58M |
|
|
AMRI
36
DELISTED
Albany Molecular Research Inc
AMRI
| $7.04M | 0.47% |
+400,056
| New | +$6.82M |
|
37
Casella Waste Systems
CWST
$5.65B
| $2.99M | 0.2% |
544,220
-11,713
| -2% | -$50.7K |
|
|
RGDX
38
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
| $2.64M | 0.18% |
6,000,000
| – | – |
|
|
AVNS
39
DELISTED
Avanos Medical
AVNS
| – | – |
-413,662
| Closed | -$18.8M |
|
40
Booking.com
BKNG
$151B
| – | – |
-950,000
| Closed | -$43.3M |
|
|
41
General Motors
GM
$80.3B
| – | – |
-1,401,965
| Closed | -$48.9M |
|
|
ACOR
42
DELISTED
Acorda Therapeutics
ACOR
| – | – |
-5,927
| Closed | -$29.1M |
|
|
ECOM
43
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| – | – |
-2,170,993
| Closed | -$46.9M |
|
|
P
44
DELISTED
Pandora Media Inc
P
| – | – |
-1,019,726
| Closed | -$18.2M |
|
|
PNK
45
DELISTED
Pinnacle Entertainment Inc.
PNK
| – | – |
-2,272,492
| Closed | -$50.6M |
|
|
EVHC
46
DELISTED
Envision Healthcare Holdings Inc
EVHC
| – | – |
-583,676
| Closed | -$60.6M |
|
|
SHPG
47
DELISTED
Shire pic
SHPG
| – | – |
-124,250
| Closed | -$26.4M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2015 Portfolio in Review
As of Q1 2015, Bridger Management held 47 positions worth $1.5B, down 5.8% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Bridger Management withdrew a net $196M in Q1 2015, closing 9 positions and reducing 8 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $60.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 50% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in Marathon Petroleum worth $58.5M.
- Bridger Management's largest Q1 2015 buy was Marathon Petroleum: 1,142,724 shares worth $58.5M.
- Bridger Management added most to Zoetis in Q1 2015, an estimated $26.3M increase.
- Bridger Management's biggest Q1 2015 reduction was Teva Pharmaceuticals, cutting an estimated $62.7M.
- Bridger Management fully exited Envision Healthcare Holdings Inc in Q1 2015, selling an estimated $60.6M.
- Bridger Management's ten largest holdings make up 47% of its $1.5B portfolio in Q1 2015.
- Bridger Management opened 6 new positions and closed 9 in Q1 2015.
- Bridger Management's portfolio value fell 5.8% quarter-over-quarter to $1.5B.
Based on Bridger Management's 13F filing for Q1 2015, filed 15 May 2015.